Navigation Links
Phase 3 Cystic Fibrosis Trial Results Presented at European Conference
Date:6/15/2009

SYDNEY, June 16 /PRNewswire-Asia/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) is pleased to announce that additional results of its recently completed international Phase III trial of Bronchitol in patients with cystic fibrosis have been presented at the 2009 European Cystic Fibrosis Conference in Brest, France.

The results were presented to the conference on Friday 12 June by Dr Diana Bilton of the Royal Brompton Hospital, London.

The trial was a multi-centre, randomised, double blind, placebo controlled, 26 week study, with an optional further 6 month open label uncontrolled period. It was conducted in 40 centres in the United Kingdom, Ireland, Australia and New Zealand.

The primary endpoint of the trial was to assess whether Bronchitol improves lung function as measured by a change in FEV1 when administered twice per day for six months.

The key secondary endpoint of the trial was to assess whether Bronchitol further improves lung function in patients already being treated with the most commonly used CF therapeutic, rhDNase. Additional endpoints included changes in the Forced Vital Capacity of the lung, pulmonary exacerbations and antibiotic use.

Safety evaluation included the incidence of adverse events and the microbiology of sputum samples.

    Clinical Results
    -- There was a clinically meaningful change from baseline (119mL) and
       placebo (93mL) at week 26 with Bronchitol for FEV1 (p<0.001).
       Importantly, treatment with Bronchitol showed an immediate and
       sustained improvement in lung function (FEV1) over the 26 weeks
       (p<0.001).
    -- For the subgroup of patients on concomitant rhDNase there was also a
       significant improvement in FEV1 from baseline (88mL) and from placebo
       (109mL) at we
'/>"/>
SOURCE Pharmaxis Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
6. Phase III Trial Finds Pharmaxis Bronchitol Effective
7. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
8. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
9. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
10. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
11. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 This is a professional and ... (mPDA) industry in Global and China. The report ... applications and industry chain structure. Global market analysis and ... on history, developments, trends and competitive landscape of the ... is also offered. , The report also focuses on ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 ... desire to stay young has groomed and nurtured ... industry worldwide. Growing emphasis on appearance maintenance is ... is a neurotoxic protein obtained from the bacterium, ... resulting in muscle relaxation. With cosmetic indications for ...
(Date:9/22/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... of its 2015 fiscal year, which ended Aug. 31, ... income of $7,839,000 in the first quarter of last ... 30, 2013, earnings per share in the current quarter ... First quarter revenues increased 15% to $67,599,000, from ...
(Date:9/22/2014)... Olso, Norway (PRWEB) September 22, 2014 ... convenient new parcel and pallet measuring device ... ScanTape™ eliminates manual data entry, offering greater ease ... time savings that result can significantly enhance productivity—an ... in industries where processing volume equals profits. ...
Breaking Biology Technology:m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 3Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7ScanTape™ Handheld Dimensioner Increases Processing Volume 2
... WORCESTER, Mass., July 14 The Huffington Post ... book (co-authored with astronomer Bob Berman) " Biocentrism." The ... understanding the universe. The Huffington Post is ranked the ... It reaches over 20 million thought-leaders, and has featured celebrity contributors ...
... , , BEDFORD, Mass., July 14 ... industry, today announced the publication of the South American ... Biomass Energy Plantations . This new study updates and expands ... - Global Tree Farm & Managed Forest Industry . ...
... July 14 The Board of Directors of,Santaris Pharma has approved the Interim Report ... The loss after tax realised in the 2nd quarter of 2009 was, ... the 2nd, quarter of 2008., - ... DKK (23,6m EUR)., - In Q2 the SPC3649 compound targeting ...
Cached Biology Technology:New Scientific Worldview 'Biocentrism' Featured in The Huffington Post - #1 Weblog in the World 2New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities 2New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities 3Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 2Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 3Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 4Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 5Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 6Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 7Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 8Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 9
(Date:9/19/2014)... the unique bioelectric signaling system of the electric fish, ... The OU researcher is working to understand how these ... used to map the world around them. Electric ... discharges a second throughout their lives. The energetic ... necessary for survival. , "There is evidence that electric ...
(Date:9/19/2014)... Nxt-ID, Inc. (Nasdaq: NXTD and NXTDW) ("Nxt-ID" or ... market, updates the "Wocket in Your Pocket" celebrity ad campaign, featuring ... weight classes, Vinny Pazienza (PAZ). , ... Thrones actor Ciaran Hinds and Sons of ... Sagal have been cast in Bleed for This . ...
(Date:9/18/2014)... located deep in the primitive brainstem has revealed how ... Harvard School of Medicine and the University at Buffalo ... the second "sleep node" identified in the mammalian brain ... to produce deep sleep. , Published online in August ... fully half of all of the brain,s sleep-promoting activity ...
Breaking Biology News(10 mins):NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3No sedative necessary: Scientists discover new 'sleep node' in the brain 2
... Regulating Agricultural Biotechnology: Economics and Policy, edited ... David Zilberman, has won the Quality of Communication ... The Award recognizes publications that demonstrate superior communication ... Regulating Agricultural Biotechnology: Economics and Policy ...
... The area covered by sea ice in the Arctic ... satellite measurements began nearly 30 years ago, opening up ... Europe and Asia that has been historically impassable. ... images acquired in early September 2007 by the Advanced ...
... 2007 One of the 2007 American Society for Microbiology ... be presented to Hung Ton-That, Ph.D., Assistant Professor in ... of Connecticut Health Center. Dr. Ton-That is being ... disease. Dr. Ton-Thats research is highly regarded, ...
Cached Biology News:Satellites witness lowest Arctic ice coverage in history 2
... dispensers save space and organize ... and other garb. They are ... for small parts used in ... acrylic. Open-slot design for easy ...
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Soil Nematode microRNA ...
... is critical to the maintenance of ... proteins as important and diverse as ... shock and stress response, antigen presentation, ... ion channels, cell cycle regulation, transcription, ...
... Proteolytic degradation is critical to ... short-lived and regulatory proteins as important ... cellular metabolism, heat shock and stress ... surface receptors and ion channels, cell ...
Biology Products: